Coya Therapeutics, Inc. held its Annual Meeting of Stockholders on June 26, 2025. During the meeting, Howard Berman, Ph.D., Arun Swaminathan, Ph.D., and Ann Lee, Ph.D., were elected as Class III directors. Additionally, the appointment of Weaver and Tidwell, L.L.P. as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. Both proposals were approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-149104), on June 26, 2025, and is solely responsible for the information contained therein.